SINGAPORE, March 9, 2025 /PRNewswire/ — On March 8, 2025, AB DAO announced that $AB has officially been listed on Hotcoin (hotcoin.com) at 18:00 (UTC+8), further expanding its global trading network and driving AB’s adoption in the Web3 ecosystem. Additionally, $AB is set to be listed on…
Month: March 2025
BARCELONA, Spain, March 10, 2025 /PRNewswire/ — During the Mobile World Congress 2025, Huawei successfully held the Digital Intelligence Talent Development Forum, attracting more than 100 customers from all over the world. At the forum, Huawei Launched the Digital Intelligence Talent…
SHENZHEN, China, March 10, 2025 /PRNewswire/ — At the Huawei Product & Solution Launch during MWC Barcelona 2025, Cao Ming, Vice President of Huawei and President of Huawei Wireless Solution, launched AI-Centric 5.5G solutions. Cao said “Mobile AI is booming, bringing three major…
SEOUL, South Korea, March 9, 2025 /PRNewswire/ — HD Hyundai Executive Vice Chairman Chung Kisun met with Palantir Technologies Inc. CEO Alex Karp to discuss the project on building AI shipyards. HD Hyundai shared that Chung recently visited Palantir’s Washington, D.C., office to meet…
HANGZHOU, China, March 9, 2025 /PRNewswire/ — Zhejiang Doer Biologics Co., Ltd. (“Doer Bio”), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its first-in-class (FIC), tri-specific agonist…
BEIJING, March 9, 2025 /PRNewswire/ — During China’s 2025 national two sessions, an 82-year-old man from Central China’s Hunan Province named Chen Junqing garnered attention. He wrote his suggestion on cigarette pack foil, which was submitted through a community legislative contact point…
Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma’s global onco-derm franchise Will leverage Sun Pharma’s global presence to accelerate patient access to…
Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma’s global onco-derm franchise Will leverage Sun Pharma’s global presence to accelerate patient access to…
Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma’s global onco-derm franchise Will leverage Sun Pharma’s global presence to accelerate patient access to…
Seventeenth Annual Competition honors innovative startups within nine categories AUSTIN, Texas, March 9, 2025 /PRNewswire/ — South by Southwest® (SXSW®) Conference and Festivals announced the winners of the 17th annual SXSW Pitch event presented by KPMG, which took place March 8-9 at the…